Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir
Insurers saw sky-high profits in Q2. Now Congress wants to take a look at their finances
Fauci: Political pressure won’t interfere with FDA decisions on COVID-19 vaccines
How Teladoc's blockbuster deal could impact the entire virtual care landscape
NIH to fund new diagnostic tests for the emerging, severe childhood illness linked to COVID-19
Healthcare employment cooled off in July, adding 156K jobs
Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan
AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan
Biopharma roundup: So far, so good for Moderna's vaccine trial, Fauci says; Gates Foundation taps Serum Institute to crank out $3 COVID shots

Featured Story

Pfizer signs up to help manufacture Gilead's scarce coronavirus-fighter remdesivir

By Eric Sagonowsky

Pfizer is among the COVID-19 vaccine frontrunners racing to deliver a safe and effective shot, and now it's chipping in with manufacturing on the therapeutic side. The Big Pharma signed on to help produce Gilead's remdesivir, which has been running short at some hard-hit U.S. hospitals.

Insurers saw sky-high profits in Q2. Now Congress wants to take a look at their finances

By Paige Minemyer

We take a look back at health insurers' financial performance, including soaring profits, in Q2.

Fauci: Political pressure won’t interfere with FDA decisions on COVID-19 vaccines

By Nick Paul Taylor

The FDA has vowed not to let political pressure to approve a COVID-19 vaccine as soon as possible interfere with the regulatory process, Anthony Fauci told Reuters. Fauci’s comments come ahead of an election season in which the availability of a vaccine could influence the vote.

How Teladoc's blockbuster deal could impact the entire virtual care landscape

By Heather Landi

Teladoc's move to acquire Livongo is shaking up the health technology market. Here's why analysts and industry leaders think the deal could significantly change the virtual care market and healthcare delivery.

NIH to fund new diagnostic tests for the emerging, severe childhood illness linked to COVID-19

By Conor Hale

While most children exposed to the novel coronavirus suffer only a mild infection, others may develop a rare but severe inflammatory reaction that attacks several organs at once, requiring intensive rescue care.

Healthcare employment cooled off in July, adding 156K jobs

By Robert King

The healthcare sector added 126,000 jobs in July, a major decline from the 358,000 jobs added in June as the industry continues to battle a financial crisis caused by COVID-19.

Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan

By Angus Liu

Takeda has added a vaccine project to its fight against the COVID-19 pandemic. The Japanese pharma, already developing coronavirus treatments, struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan, aiming for 250 million doses per year.

AstraZeneca taps JCR Pharmaceuticals, Daiichi Sankyo and other local pharmas to supply COVID-19 shots to Japan

By Fraiser Kansteiner

Japan called dibs on 120 million doses of AstraZeneca and the University of Oxford's coronavirus vaccine candidate. The British drugmaker aims to import part of that supply, tapping Japan's JCR pharmaceuticals to produce the remaining vaccine substance. Meanwhile, Daiichi Sankyo, Meiji Seika Pharma and KM Biologics will also support supply work in Japan, AZ said.

Biopharma roundup: So far, so good for Moderna's vaccine trial, Fauci says; Gates Foundation taps Serum Institute to crank out $3 COVID shots

By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner

Moderna's phase 3 enrollment progress won a thumbs up from NIAID chief Anthony Fauci. The Gates Foundation tapped Serum Institute of India to produce low-cost shots. The NIH launched a research effort to create tests for a childhood COVID-19 complication. And researchers are eyeing ACE2 treatments for COVID-19.

COVID-19 Tracker